Key Highlights

  • IMI LSE:IMI gained 0.85% on 8 September 2026, rising 26p to close at 3,094p. The shares traded between 3,060p and 3,098p during the session.
  • The stock has gained approximately 35% over the past year, demonstrating strong relative momentum.
  • IMI delivered a strong first half, with Revenue increasing 6% to £1.159 billion and adjusted operating profit rising 10% to £217 million.
  • Adjusted Operating Margin improved to 18.7%, while adjusted basic EPS increased 13% to 63.4p.
  • Free Cash Flow surged 472% to £171 million, providing greater financial flexibility for Investment and Shareholder returns.
  • IMI maintained its target of delivering a sixth consecutive year of mid-single-digit organic revenue growth in 2026.
  • The company is executing a £500 million share buyback programme, with £250 million completed by 30 June 2026.
  • The Interim Dividend was increased 10% to 12.1p per share, adding another shareholder-return catalyst.

Why IMI LSE:IMI Is in Focus

IMI LSE:IMI continued its positive share-price momentum on 8 September 2026, rising 0.85% to 3,094p. The stock reached 3,098p intraday, just below the recent 52-week high of around 3,166p, demonstrating that investors remain willing to value the engineering specialist at elevated levels.

The latest advance comes against a backdrop of strong financial execution. IMI's first-half results showed that the company is simultaneously growing revenue, expanding margins, generating substantially more cash and returning Capital to shareholders.

That combination is particularly important for investors because IMI's strategy is focused on structural themes rather than purely cyclical demand. The company identifies energy, automation and healthcare as Long-term Growth trends supporting Demand for its highly engineered fluid and motion-control products.

Why Did LSE:IMI Rise 0.85% on 8 September 2026?

There was no major new Earnings release on 8 September to explain the entire move. Instead, the gain appears to reflect continued investor confidence following IMI's strong first-half results, its maintained full-year guidance and ongoing capital-return programme.

The company was also active in its share buyback programme around the latest trading sessions. IMI announced that it had purchased shares for cancellation at an average price of 3,073.29p on 7 September. The company has been regularly repurchasing shares since launching its £500 million programme earlier in 2026.

The combination of a rising share price and continued Buybacks suggests that investors remain focused on IMI's ability to compound Earnings Per Share while maintaining disciplined capital allocation.

Strong First-Half Results Strengthen the Investment Case

IMI's first-half 2026 results provide the strongest fundamental explanation for the stock's continued strength.

Revenue increased 6% to £1.159 billion, including 5% organic growth. Adjusted operating profit rose 10% to £217 million, with adjusted operating margin increasing by 50 basis points to 18.7%.

Profit before tax increased 10% to £209 million, while adjusted basic EPS increased 13% to 63.4p. On a statutory basis, operating profit increased 27% to £201 million and basic EPS jumped 26% to 57.7p.

These numbers demonstrate that IMI is not merely growing sales. It is also generating Operating Leverage and improving profitability.

Cash Generation Is a Major Positive

One of the most encouraging developments was the dramatic improvement in cash generation.

Adjusted Operating Cash Flow increased 32% to £208 million, while free cash flow before corporate activity rose from £30 million to £171 million. That represents a 472% increase.

The stronger cash position gives IMI greater flexibility to fund organic investment, acquisitions and share buybacks without placing excessive pressure on the balance sheet.

Net Debt to adjusted EBITDA was 1.2 times, down from 1.4 times a year earlier, reinforcing the company's financial discipline.

For investors, this is an important part of the LSE:IMI story because sustained free-cash-flow generation can support long-term dividend growth, acquisitions and further buybacks.

Energy, Automation and Healthcare Remain Key Growth Drivers

IMI's long-term growth strategy is built around structural demand in energy, automation and healthcare.

The company supplies highly engineered components and systems that are critical to the operation of customer equipment. This gives IMI an attractive position in markets where reliability, efficiency and technical expertise are more important than simply offering the lowest-cost product.

Its portfolio also benefits from a substantial aftermarket business. IMI says approximately 45% of its revenue comes from aftermarket activities, providing recurring demand alongside new-equipment sales.

This recurring element can make earnings more resilient during periods when capital-equipment demand slows.

Automation Provides a Major Growth Opportunity

Automation remains one of the strongest structural themes supporting IMI.

The company's Automation platform benefited from good organic growth during the first half, while Process Automation continues to benefit from a strong order book. Management's earlier guidance indicated that Industrial Automation was expected to remain broadly stable to modestly higher organically.

The long-term opportunity comes from businesses investing in productivity, precision, energy efficiency and automated processes.

IMI's highly specialised valves, actuators and control systems can therefore benefit from increased automation investment without requiring the company to compete directly with large-scale equipment manufacturers.

Energy Demand Creates Another Structural Tailwind

Energy is another important growth theme.

IMI provides technology used in energy infrastructure and industrial applications where customers increasingly require greater efficiency, reliability and lower emissions.

The company has also been investing in its energy-related capabilities. In May, IMI announced the opening of a new California Facility supporting growing demand across energy markets, highlighting its continued investment in areas where long-term infrastructure spending could drive demand.

The expansion of power infrastructure, industrial efficiency requirements and the increasing complexity of energy systems could provide a long runway for specialist engineering suppliers.

Healthcare and Life Technology Add Resilience

Healthcare provides another Diversification benefit.

IMI's Life Technology platform includes exposure to Climate Control and Life Science & Fluid Control. Management reported resilient healthcare demand, while the global life-science device market showed further signs of stabilisation.

This is important because healthcare-related demand can be less cyclical than some industrial markets.

However, IMI is also investing to strengthen Cybersecurity and accelerate growth in data-centre-related applications within Life Technology, which could create additional opportunities but also increases near-term investment requirements.

Buyback and Dividend Strengthen Shareholder Returns

Capital allocation is becoming an increasingly important part of the LSE:IMI investment case.

IMI launched a £500 million share buyback programme in March 2026. Half of the programme had already been completed by the end of June, with management expecting the weighted-average number of shares to fall to approximately 239 million for the full year.

At the same time, the interim dividend increased 10% to 12.1p per share.

If the company continues to combine organic earnings growth with share-count reduction, adjusted EPS could potentially grow faster than underlying revenue.

What Investors Should Watch Next

The key issue for investors is whether IMI can maintain its sixth consecutive year of mid-single-digit organic revenue growth.

Investors should watch order intake, particularly within Process Automation, as well as demand across Industrial Automation and Life Technology.

Margin progression is another important indicator. IMI has demonstrated an ability to expand margins, and investors will want evidence that productivity improvements and commercial discipline can continue offsetting inflationary and investment pressures.

Cash conversion and leverage should also remain on the watchlist because continued buybacks and potential acquisitions require strong free cash flow.

LSE:IMI Outlook

The 0.85% gain on 8 September 2026 adds to a strong longer-term performance for IMI LSE:IMI. The company has delivered six consecutive years of mid-single-digit organic revenue growth as a target, while the first half of 2026 demonstrated improving margins, earnings and cash generation.

The bullish case rests on structural growth in automation, energy and healthcare, combined with IMI's specialist engineering capabilities, recurring aftermarket revenues and strong cash-generation profile.

The £500 million buyback and 10% dividend increase provide additional support for shareholder returns.

The main risks include a slowdown in industrial capital expenditure, weaker global Manufacturing activity, project delays, currency movements and valuation risk following the stock's substantial one-year appreciation.

For now, however, the combination of 6% revenue growth, 10% adjusted operating-profit growth, 13% EPS growth, dramatically stronger free cash flow and continued share buybacks explains why IMI LSE:IMI remains firmly in focus after its 0.85% rise on 8 September 2026.

Top of Form

Bottom of Form